Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells: involvement of cAMP-responsive element

The Journal of Endocrinology
M-J KimY-H Jo

Abstract

Glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (EX) have been considered as a growth factor implicated in pancreatic islet mass increase and beta-cell proliferation. This study aimed to investigate the effect of EX on cyclin D1 expression, a key regulator of the cell cycle, in the pancreatic beta-cell line INS-1. We demonstrated that EX significantly increased cyclin D1 mRNA and subsequently its protein levels. Although EX induced phosphorylation of Raf-1 and extracellular-signal-regulated kinase (ERK), both PD98059 and exogenous ERK1 had no effect on the cyclin D1 induction by EX. Instead, the cAMP-elevating agent forskolin induced cyclin D1 expression remarkably and this response was inhibited by pretreatment with H-89, a protein kinase A (PKA) inhibitor. Promoter analyses revealed that the cAMP-responsive element (CRE) site (at position -48; 5'-TAACGTCA-3') of cyclin D1 gene was required for both basal and EX-induced activation of the cyclin D1 promoter, which was confirmed by site-directed mutagenesis study. For EX to activate the cyclin D1 promoter effectively, CRE-binding protein (CREB) should be phosphorylated and bound to the putative CRE site, according to the results of electrophoretic mobility shift and chr...Continue Reading

Citations

Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mark O HuisingWylie W Vale
Oct 15, 2010·The Journal of Biological Chemistry·Scott A SoleimanpourDoris A Stoffers
Jan 25, 2008·The Journal of Biological Chemistry·Zhengyu Liu, Joel F Habener
Jan 19, 2008·Diabetes, Obesity & Metabolism·R LupiP Marchetti
Oct 13, 2009·Diabetes, Obesity & Metabolism·Yanmei LiuMichele Solimena
Dec 17, 2008·Pharmacological Reviews·Wook Kim, Josephine M Egan
Apr 24, 2008·The Journal of Clinical Investigation·Rodger E TiedemannA Keith Stewart
Jul 25, 2009·Molecular Endocrinology·Lu Mei HeJake A Kushner
Jul 20, 2007·Journal of Cellular and Molecular Medicine·M HermannP Hengster
Jul 1, 2011·Experimental Diabetes Research·Bernard PorthaJamileh Movassat
Jun 12, 2008·Diabetes·Woo-Jin SongMehboob A Hussain
Jun 2, 2009·Journal of Pharmacological Sciences·Noritaka NakamichiYukio Yoneda
Feb 20, 2007·Pharmacology & Therapeutics·Máire E Doyle, Josephine M Egan
Feb 1, 2007·Current Opinion in Organ Transplantation·Michael F Crutchlow, Doris A Stoffers
Feb 12, 2009·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·H HuS Zhu
Aug 2, 2014·Molecular Endocrinology·Zhenshan ZhaoJustin P Annes
Mar 10, 2016·Hormone Molecular Biology and Clinical Investigation·Morgane RousselStéphane Dalle
Nov 3, 2010·Annals of the New York Academy of Sciences·Jeremy A Lavine, Alan D Attie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.